- Chronic lymphocytic leukaemia2013 | First Faculty of Medicine
- New genetic predisposition linked to chronic lymphocytic leukaemia2013 | First Faculty of Medicine
- Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL)2013 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine
- Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL) Czech Group for Chronic Lymphocytic Leukaemia, section of the Czech Society of Haematology, CzMA2016 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Atypical picture of colon infiltration with lymphoma in a patient with chronic lymphocytic leukaemia2015 | Faculty of Medicine in Hradec Králové
- Recommendations for chronic lymphocytic leukaemia diagnosis and therapy 20212021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Changes in the immune system in untreated patients with chronic lymphocytic leukaemia - part 2: innate immune system +12021 | Faculty of Medicine in Hradec Králové
- Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice2011 | First Faculty of Medicine
- Development of Richter's transformation in a patient with refractory chronic lymphocytic leukaemia on ibrutinib therapy2020 | Faculty of Medicine in Hradec Králové
- Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukaemia: Dead Yet, or Alive and Kicking?2021 | Faculty of Medicine in Hradec Králové
- Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients2015 | Publication without faculty affiliation
- Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients2015 | Faculty of Medicine in Hradec Králové
- Development of chronic lymphocytic leukaemia during ipilimumab therapy in a patient with metastatic melanoma2016 | Third Faculty of Medicine, Second Faculty of Medicine
- Skipping a step or "impatientitis": what happened to the design of randomized clinical trials in chronic lymphocytic leukaemia?2021 | Faculty of Medicine in Hradec Králové
- Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice2011 | Faculty of Medicine in Hradec Králové
- Richter transformation of chronic lymphocytic leukaemia in the era of treatment with B-cell signalling pathway inhibitors2020 | First Faculty of Medicine
- Changes in the immune system of untreated patients with chronic lymphocytic leukaemia - Part 1: Adaptive immunity2021 | Faculty of Medicine in Hradec Králové
- Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT2023 | Publication without faculty affiliation
- Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial2019 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial2023 | Faculty of Medicine in Hradec Králové
- Idelalisib in the treatment of chronic lymphocytic leukaemia2015 | First Faculty of Medicine
- Advances in the treatment of chronic lymphocytic leukaemia2013 | First Faculty of Medicine
- Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group2021 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL) - 20182018 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine